Evotec SE (EVOTF)
3.890
0.00 (0.00%)
USD |
OTCM |
Aug 27, 16:00
Evotec EPS Diluted (Quarterly) : -0.3051 for June 30, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.3051 |
| March 31, 2026 | -0.8034 |
| December 31, 2025 | 0.0958 |
| September 30, 2025 | -0.2834 |
| June 30, 2025 | -0.2775 |
| March 31, 2025 | -0.1872 |
| December 31, 2024 | -0.2453 |
| September 30, 2024 | -0.2455 |
| June 30, 2024 | -0.5764 |
| March 31, 2024 | -0.1266 |
| December 31, 2023 | -0.098 |
| September 30, 2023 | -0.2395 |
| June 30, 2023 | -0.0918 |
| March 31, 2023 | -0.0843 |
| December 31, 2022 | -0.157 |
| September 30, 2022 | -0.2693 |
| June 30, 2022 | -0.1683 |
| March 31, 2022 | -0.465 |
| December 31, 2021 | -0.204 |
| September 30, 2021 | 0.962 |
| June 30, 2021 | 0.4403 |
| March 31, 2021 | 0.3869 |
| December 31, 2020 | 0.0019 |
| September 30, 2020 | -0.0109 |
| June 30, 2020 | -0.0716 |
| Date | Value |
|---|---|
| March 31, 2020 | 0.1246 |
| December 31, 2019 | 0.0581 |
| September 30, 2019 | 0.1414 |
| June 30, 2019 | -0.0179 |
| March 31, 2019 | 0.0994 |
| December 31, 2018 | 0.2414 |
| September 30, 2018 | 0.2726 |
| June 30, 2018 | 0.1191 |
| March 31, 2018 | 0.0288 |
| December 31, 2017 | 0.0841 |
| September 30, 2017 | 0.0191 |
| June 30, 2017 | 0.022 |
| March 31, 2017 | 0.0533 |
| December 31, 2016 | 0.1185 |
| September 30, 2016 | 0.0781 |
| June 30, 2016 | 0.0339 |
| March 31, 2016 | -0.011 |
| December 31, 2015 | 0.0438 |
| September 30, 2015 | -0.0222 |
| June 30, 2015 | 0.1217 |
| March 31, 2015 | -0.0112 |
| December 31, 2014 | 0.0125 |
| September 30, 2014 | -0.0397 |
| June 30, 2014 | -0.0044 |
| March 31, 2014 | -0.0411 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Sartorius AG | 0.2219 |
| SCHOTT Pharma AG & Co. KGaA | 0.0749 |
| Agilent Technologies, Inc. | 1.198 |
| Bio-Rad Laboratories, Inc. | 13.85 |
| Bruker Corp. | -0.413 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -54.24M |
| Revenue (Quarterly) | 166.82M |
| Total Expenses (Quarterly) | 221.06M |
| Enterprise Value | 702.67M |
| Gross Profit Margin (Quarterly) | -1.10% |
| Profit Margin (Quarterly) | -32.51% |
| Earnings Yield | -33.31% |
| Normalized Earnings Yield | -24.59 |